Icon
+91 94997 68112
Login Register

Suprenza - (15, 30, 37.5mg TABLET, ORALLY DISINTEGRATING;ORAL)

Phentermine Hydrochloride CITIUS PHARMS
15, 30, 37.5mg TABLET, ORALLY DISINTEGRATING;ORAL
Less Than $1000 mn
Less Than 5
Less Than 5
None None
Less Than 5
Less Than 5
Used as part of a short-term plan, along with a low calorie diet, for weight reduction. It is used in obese patients who have not been able to lose weight with diet and exercise alone.
Yes
****** ** ***** ** **** * **** ** **** ******** *** ****** '***, ******** ** **** ****. *** **** ****** *** ****** ** ** ****** ****, ********** *** ********* **** ****** ***** *** ***** ** ********** *** *** *****, ** ****** * ******** ****** ** **** ***.
Suprenza Patent 1 Patent 2
***** ****** ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
***** ****** *** \ *** *** *, **** ******* ******** ******** ** *** *, ****
  1. *** *, **** : ****** ******** ***** ********* *** **** **** **** ** **** ****** '***, ******** ** **** ****.
  2. **** *, **** : ***** **** ****** ** ******** ** ********.
  3. *** **, **** : ********** **** ****** *** ********* ***** *** ***** ** ********** *** *** *****.
  4. *** *, **** : ***** ******** *** **** ******** *** ************ ** *** *******

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.